Piramal starts Phase-II clinical trials of diabetes drug

Piramal Life Sciences has started Phase-II clinical trials of a molecule ‘P1736-05, aimed at treating diabetes, in Europe and India. P1736-05 is likely to provide a safe and effective therapeutic option to type-2 diabetic patients.

While the company has been granted an approval by the Indian regulatory authorities, in Europe various EU regulatory authorities like CCMO of Netherlands and NIP of Hungary have granted an approval for conducting the trials.